These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6576979)

  • 21. Multiple Ia-like molecules characterize HLA-DR2-associated haplotypes which differ in HLA-D.
    Nepom GT; Nepom BS; Wilson ME; Mickelson E; Antonelli P; Hansen JA
    Hum Immunol; 1984 Jul; 10(3):143-51. PubMed ID: 6430842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequencing of HLA-D in responders and nonresponders to short ragweed allergen, Amb a V.
    Zwollo P; Ehrlich-Kautzky E; Scharf SJ; Ansari AA; Erlich HA; Marsh DG
    Immunogenetics; 1991; 33(2):141-51. PubMed ID: 1999353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Class II major histocompatibility complex restriction of human T cell responses to short ragweed allergen, Amb a V.
    Huang SK; Zwollo P; Marsh DG
    Eur J Immunol; 1991 Jun; 21(6):1469-73. PubMed ID: 2044656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters.
    Cohen N; Brautbar C; Font MP; Dausset J; Cohen D
    Immunogenetics; 1986; 23(2):84-9. PubMed ID: 3007344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serologic dissection of HLA-D specificities by the use of monoclonal antibodies. II. Distinction between HLA-Dw2 and HLA-Dw12.
    Kasahara M; Takenouchi T; Ikeda H; Ogasawara K; Okuyama T; Ishikawa N; Wakisaka A; Kikuchi Y; Aizawa M
    Immunogenetics; 1983; 18(5):525-36. PubMed ID: 6196285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MHC class II sequences of an HLA-DR2 narcoleptic.
    Lock CB; So AK; Welsh KI; Parkes JD; Trowsdale J
    Immunogenetics; 1988; 27(6):449-55. PubMed ID: 3259543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Both alpha and beta chains of HLA-DC class II histocompatibility antigens display extensive polymorphism in their amino-terminal domains.
    Schenning L; Larhammar D; Bill P; Wiman K; Jonsson AK; Rask L; Peterson PA
    EMBO J; 1984 Feb; 3(2):447-52. PubMed ID: 6585297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete characterization and sequence of an HLA class II DR beta chain cDNA from the DR5 haplotype.
    Tieber VL; Abruzzini LF; Didier DK; Schwartz BD; Rotwein P
    J Biol Chem; 1986 Feb; 261(6):2738-42. PubMed ID: 3456344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional definition of HLA-DR and -DQ epitopes specific for DR2-short, DwFJO haplotype.
    Zeliszewski D; Sterkers G; Freidel C; Gebuhrer L; Betuel H; Levy JP
    Immunogenetics; 1986; 23(6):385-92. PubMed ID: 2424833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The MT3 specificity resides on a novel human class II antigen distinct from the HLA-DR antigen and DC-like antigen.
    Yabe T; Suzuki M; Satake M; Juji T; Hamaguchi H
    Immunogenetics; 1984; 20(2):155-67. PubMed ID: 6205988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of MHC class II antigenic determinants in the function of human antigen binding T8+ cells, monocytes and helper and suppressor factors.
    Lehner T; Jones T
    Clin Exp Immunol; 1984 Jun; 56(3):683-93. PubMed ID: 6204796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signal sequences distinguish class II histocompatibility antigen beta chains of different loci.
    Gustafsson K; Wiman K; Larhammar D; Rask L; Peterson PA
    Scand J Immunol; 1984 Jan; 19(1):91-7. PubMed ID: 6422542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-D typing in multiple sclerosis: Israelis tested with European homozygous typing cells.
    Brautbar C; Amar A; Cohen N; Oksenberg J; Cohen I; Kahana E; Bloch D; Alter M; Grosse-Wilde H
    Tissue Antigens; 1982 Mar; 19(3):189-97. PubMed ID: 6953617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural model for T-cell recognition of HLA class II-associated alloepitopes.
    Reinsmoen NL; Bach FH
    Hum Immunol; 1990 Jan; 27(1):51-72. PubMed ID: 1689285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A homozygous human cell line contains three subsets of HLA-DR-like antigens distinguishable by amino acid sequencing.
    Andrews DW; Bono MR; Strominger JL
    Biochemistry; 1982 Dec; 21(26):6625-8. PubMed ID: 6961940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Separation of three class II antigens from a homozygous human B cell line.
    Shackelford DA; Lampson LA; Strominger JL
    J Immunol; 1983 Jan; 130(1):289-96. PubMed ID: 6600185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissection of the D-region of the human major histocompatibility complex by means of induced mutations in a lymphoblastoid cell line.
    DeMars R; Chang CC; Rudersdorf RA
    Hum Immunol; 1983 Oct; 8(2):123-39. PubMed ID: 6417067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial N-terminal sequence analysis of DRw53 antigens: the beta-chains of DRw53 antigens are structurally distinct from beta-chains of DR and DQ antigens.
    Obata F; Endo T; Tate G; Miyokawa N; Katagiri M; Kashiwagi N
    J Immunol; 1986 Mar; 136(6):2187-90. PubMed ID: 3456389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DQ structural polymorphism in HLA-DR2 associated HLA-D clusters.
    Nakatsuji T; Moriya K; Ando A; Inoko H; Tsuji K
    Hum Immunol; 1986 Jun; 16(2):157-62. PubMed ID: 2941397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.